Anebulo Pharmaceuticals, Inc. - Neraca (Quarterly)

Anebulo Pharmaceuticals, Inc.
US ˙ NasdaqCM ˙ US0345691036

Talaan ng Balanse (Quarterly)

Neraca Anebulo Pharmaceuticals, Inc. menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
Cash 20 19 18 17 15 19 16 14 11 9 7 5 3 1 15 13
Change (%) -3.89 -6.24 -8.11 -12.08 32.07 -14.88 -13.39 -20.60 -24.24 -22.02 -22.54 -39.89 -54.62 968.11 -11.46
Assets Current 22 21 19 17 16 20 17 14 12 9 7 5 4 2 15 14
Change (%) -5.33 -7.49 -9.05 -9.68 27.19 -14.77 -14.54 -19.14 -22.47 -24.66 -21.21 -34.68 -44.06 684.48 -10.31
Assets 22 21 19 17 16 20 17 14 12 9 8 6 4 2 16 14
Change (%) -5.33 -7.49 -9.05 -9.68 27.19 -14.77 -14.54 -19.14 -22.47 -17.10 -20.07 -32.07 -39.41 541.88 -11.57
Liabilities 0 1 0 0 1 1 1 1 1 1 1 1 0 1 1 1
Change (%) 151.50 -91.78 71.75 497.52 36.22 96.57 8.65 -28.32 -32.96 41.45 -0.32 -74.21 118.44 54.39 -37.87
Equity 21 20 19 17 15 19 16 13 11 8 6 5 4 2 15 13
Change (%) -7.10 -4.92 -9.26 -12.21 26.88 -18.84 -16.59 -18.08 -21.41 -22.13 -23.15 -23.52 -50.20 688.03 -10.02
Liabilities And Stock Equity 22 21 19 17 16 20 17 14 12 9 8 6 4 2 16 14
Change (%) -5.33 -7.49 -9.05 -9.68 27.19 -14.77 -14.54 -19.14 -22.47 -17.10 -20.07 -32.07 -39.41 541.88 -11.57

Source: Capital IQ

Other Listings
DE:214 € 1.53
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista